Plants produce a vast and diverse organic compounds, which do not appear to participate directly in growth and development.These substances traditionally referred to as secondary metabolites which terpenes are one of them.
This presentation deals with Thiamine Pyrophosphate (TPP), Pyridoxal Phosphate (PLP) and Coenzyme- A .
A brief description about Vitamins and Co enzymes. Then synthesis and application of PLP, TTP and Co-enzyme A
Plants produce a vast and diverse organic compounds, which do not appear to participate directly in growth and development.These substances traditionally referred to as secondary metabolites which terpenes are one of them.
This presentation deals with Thiamine Pyrophosphate (TPP), Pyridoxal Phosphate (PLP) and Coenzyme- A .
A brief description about Vitamins and Co enzymes. Then synthesis and application of PLP, TTP and Co-enzyme A
Thiamine (vitamin B1) and biochemical aspects of beriberirohini sane
A comprehensive presentation on Thiamine and biochemical aspects of Beriberi for MBBS, BDS, B Pham and Biotechnology students to facilitate easy leaning.
What are terpenes ?
Terpenes are secondary metabolites which are produced by Plants for their defense mechanism or required as per their metabolism. They are unsaturated and conjugated compounds may be aromatic or alliphatic
Cellular Energy Transfer (Glycolysis and Krebs Cycle) and ATPmuhammad aleem ijaz
This presentation is all about Cellular Energy Transfer with reference to Glycolysis and Kreb Cycle with all their stages involved.
It also includes ATP production in the body, its importance, structure.
Also contains a comparison of energy production in Krebs and Glycolysis cycle.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
More Related Content
Similar to onecarbonmetabolismbscclass-161115134043 (1).pdf
Thiamine (vitamin B1) and biochemical aspects of beriberirohini sane
A comprehensive presentation on Thiamine and biochemical aspects of Beriberi for MBBS, BDS, B Pham and Biotechnology students to facilitate easy leaning.
What are terpenes ?
Terpenes are secondary metabolites which are produced by Plants for their defense mechanism or required as per their metabolism. They are unsaturated and conjugated compounds may be aromatic or alliphatic
Cellular Energy Transfer (Glycolysis and Krebs Cycle) and ATPmuhammad aleem ijaz
This presentation is all about Cellular Energy Transfer with reference to Glycolysis and Kreb Cycle with all their stages involved.
It also includes ATP production in the body, its importance, structure.
Also contains a comparison of energy production in Krebs and Glycolysis cycle.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Artificial Intelligence to Optimize Cardiovascular Therapy
onecarbonmetabolismbscclass-161115134043 (1).pdf
1. B A S A L I N G A P P A B G
D M L T . , B M L T . , B S B T . ,
M . S C . M E D I C A L B I O C H E M I S T R Y
D E P ' T O F B I O C H E M I S T R Y
J S S M E D I C A L C O L L E G E
One Carbon Metabolism
2. FOLIC ACID
Folic acid (or folate), which plays a key role in one-
carbon metabolism, is essential for the
biosynthesis of several compounds.
Chemically folic acid is pteroyl-glutamic acid made
up of pteridne nucleus- amino benzoic acid
(PABA)and glutamic acid.
The role of folic acid is that it acts as a carrier of
one carbon groups or moities required in
metabolism.
3. Structure of folic acid is shown below. Chemically
called pteroyl glutamic acid (PGA).
There are at least three chemically related
compounds of nutritional importance which occur in
natural products, all may be termed pteroyl
glutamates.
4.
5. These three compounds differ only in the number of
glutamic acid residues attached to pteridine PABA
complex (pteroic acid).
Monoglutamate: Having one glutamic acid. It is
synonymous
with vitamin Bc.
• Triglutamate: Having three glutamic acid residues.
This substance once designated as “fermentation factor”.
• Heptaglutamate: Having seven glutamate
residues,synonymous with vitamin Bc conjugate of
yeast.Pteroyl glutamic acid is liberated from these
conjugates by enzymes called conjugases.
6. Biological “Active” Forms
Active “coenzyme” form of the vitamin is the reduced
tetra hydrderivative,Tetrahydrofolate reductase
FH4, obtained by addition of four hydrogen's to the
pteridne moiety at 5, 6, 7 and 8 position.
Structure of tetrahydrofolate is shown below.
8. Folic acid is reduced by dihydrofolate reductase in
two steps:
First to dihydrofolic acid (DHFA),also called
dihydrofolate and then converted to tetra
hydrofolate (THFA).
The double bonds at N-atom 5 and 8 as shown in
above figure are reduced .
9. The one carbon groups are as
Methyl (-CH3)
Methylene (=CH2)
Methenyl (=CH-)
Formyl (-HCO)
Formimino(-CH=NH-)
Hydroxy methyl (-CH2 –OH).
All these one carbon groups which are carried by
folic acid .
10. Sources of One Carbon
Serine
Glycine
Histidine
Tryptophan
11.
12.
13. Metabolism of one carbon metabolism
One carbon metabolism is basically indicates that
there will be a donation of carbon atom in variety of
metabolic reaction.
Some of metabolic reactions which will need to carry
out function in our body,so we need a C-atom ,and
that has to be donated ,so it is going to do that so
that will be done at tetrahydro folate(THF)
14.
15. Basically THF it carries a one carbon derivative and
that will be donated in some other metabolic
reactions.
Here so the THF is also referred as vitB9, so there
are THF derivatives which are Participating in one
carbon metabolismon they have
16. N10 –formyl THF (-CHO)
N5 ,N10 Methyl THF (-CH=)
N5 ,N10 Methylene THF (-CH2-)
N5 –Methyl THF (-CH3)
Now to THF in order to make all these have different
types of folate derivatives ,so we need again a
vitB6,vitB2 ,VitB12, So these are the other water
Soluble vitamins but they are necessary for the
THF,to get into all their derivatives.
17. So now let us one carbon metabolism is go on in our
body ,what are reactions shunts or participating in
one carbon metabolism,
So we get folate (from green leafy vegetables)usually
folate we get as polyglutamate from of folate and the
intestine and glutamates are removed and
monoglutamate are just fold is absorbed and once
its,in our body.
It will be converted to dihydrofolate (DHF)by an
enzyme dihydrofolate reductase (DHFR).
18. So now we are going to convert folate into
dihydrofolate by an enzyme DHFR.
Folate Dihydro folate reductase Dihydrofolate
Now the DHF is converted THF By the same enzyme
DHFR applies aspects for this methotrexate(Basically
it is a anticancer drug which is going to DHFR enzyme
there by converting folate into THF is decrease that s
all ,so anyway
19. Now what happens to THF ,will interact by a seine
,SHMT(serine hydroxyl methoxy transferase)this
SHMT it needs PLP(pyridoxal phosphate ) as a
coenzyme(VitB6)this is needed to make THF
derivative.
So SHMT while transferase is going to take a methyl
form serine and side chain methyl group ie attached
to hydroxyl group there,ie in the side chain,CH2 is
taken from serine .
20. So this serine will be attached to the THF and the
compund that will get
N5 ,N10 Methylene THF (-CH2-)and it will get
glycine .This is a reversible reaction.
THF serine
N5,N10 methylene THF Glycine
21. Once it get a N5 ,N10 methylene THF ,So it has three
fates here,
1. It will be used as a coenzyme by thymidilate
synthase enzyme,This TS Which is going to convert
dUMP (deoxy uridine monophosphate) into
TMP(Thymidilate monophosphate).
dUMP TMP
22. HISTIDINE: It is a source of formimino group
during its catabolism and transfers this formimino
group to THFA resulting in N5 form imino THFA .
N5 N10 methenyl THFA can also give raise to
formimino THFA as well as N5 formyl THFA.
25. UTILISATION OF ONE CARBON
Synthesis of methionine :
Methyl group of methyl cobalmine (VitB12) is used
to synthesize methionine from homocysteine .The
methyl group which is donated by methyl tetra
hydro folate(MTHF).
The methionine as SAM then donates this methyl
group in the synthesis of many important compunds
like
Choline
Creatine
Epinephrine etc .
26. IS Cobalmine which leads to folate deficiency ?
Why because the methyl tetrahydrofolate is not
utilized so this called folate trap or methyl trap.
27. PURINE SYNTHESIS
Ionisine monophosphate (IMP) synthesis mainly it
requires N5,N10 Methenyl tetrahydrofolate and
formyl tetrahydrofolate.
AMP and GMP both are significantly symthesized
from IMP.
Ultimately ATP and GTP These are formed from
AMP And GMP respectively which are required for
the DNA synthesis.
28. PYRIMIDINE SYNTHESIS
Thymidilate (TMP)is synthesized from deoxy
uridilate using N5,N10 methylene THF.
It is used in DNA synthesis.
In this Process tetrahydrofolate is simultaneously
oxidised to dihydrofolate which must be reconverted
to THF for reuse
29. Formyl tRNA
Formyl THF is required for the formation of formyl
methionine tRNA needed in Protein Synthesis in
Prokaryotes and Mitochondria.
30.
31. Deficiency of folic acid
Megaloblastic anaemia
Homocystinuria
Birth defect.
FIGLU Excretion Test:
Folate deficiency blocks the last step of histidine
breakdown or catabolism ,due to lack of
tetrahydrofolate (THF ).
This results in the accumulation of
FIGLU(Formimino glutamate ) in the body, which
leads to increased excretion of FIGLU in urine.
It is an Intermediate of Histidine metabolism
33. References
Text book of biochemistry – D M vasudevan,
Text book of biochemistry- S K Guptha
Illustrated biochemistry – Lippincott's
Text book of biochemistry – Pankaja naik